Sebaceous carcinoma: the great masquerader

被引:70
作者
Buitrago, William [2 ,3 ]
Joseph, Aaron K. [1 ,4 ]
机构
[1] Skin & Laser Surg Associates, Pasadena, TX 77504 USA
[2] Baylor Coll Med, Med Sci Training Program, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[4] Univ Texas Houston, Sch Med, Dept Dermatol, Houston, TX USA
关键词
Mohs micrographic surgery; sebaceous carcinoma; sebaceous gland; sebaceous gland carcinoma; skin cancer;
D O I
10.1111/j.1529-8019.2008.00247.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sebaceous carcinoma (SC) is a rare tumor with a high rate of local recurrence and metastasis to lymph nodes and organs. The majority of SCs occur in the periocular region frequently presenting as painless, round subcutaneous nodules with a high tendency of diffuse and invasive growth in the eyelid and conjunctiva. It frequently masquerades as inflammatory conditions or as other tumors leading to delay in diagnosis, inappropriate treatment and increased morbidity and mortality. Sebaceous carcinoma is associated with Muir-Torre syndrome, a genetic condition presenting with sebaceous skin tumors associated with internal malignancy. Therefore, SC patients must be carefully evaluated and referred to an internist or gastroenterologist when indicated. Surgery is the definitive therapy for SC. In recent years, less radical surgical strategies are being used with improved outcomes. Current studies demonstrate that Mohs micrographic surgery (MMS) provides maximal tissue conservation and lower recurrence rates. Greater awareness and understanding of SC and its behavior has led to earlier diagnosis and appropriate treatment.
引用
收藏
页码:459 / 466
页数:8
相关论文
共 75 条
[31]  
Howrey RP, 1998, CANCER, V83, P767, DOI 10.1002/(SICI)1097-0142(19980815)83:4<767::AID-CNCR20>3.3.CO
[32]  
2-K
[33]   Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid [J].
Husain, Amina ;
Blumenschein, George ;
Esmaeli, Bita .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2008, 47 (03) :276-279
[34]   FNA diagnosis of recurrent sebaceous carcinoma [J].
Jain, P ;
Nanda, A ;
Handa, U ;
Bal, A ;
Mohan, H ;
Gupta, SK .
DIAGNOSTIC CYTOPATHOLOGY, 2006, 34 (02) :124-126
[35]  
KASS LG, 1990, OPHTHALMOLOGY, V97, P2
[36]   SEBACEOUS CARCINOMA OF THE VULVA [J].
KAWAMOTO, M ;
FUKUDA, Y ;
KAMOI, S ;
SUGISAKI, Y ;
YAMANAKA, N .
PATHOLOGY INTERNATIONAL, 1995, 45 (10) :767-773
[37]   Sebaceous carcinoma arising in nevus sebaceus of Jadassohn: A clinicopathological study of five cases [J].
Kazakov, Dmitry V. ;
Calonje, Eduardo ;
Zelger, Bernhard ;
Luzar, Bostjan ;
Belousova, Irena E. ;
Mukensnabl, Petr ;
Michal, Michal .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2007, 29 (03) :242-248
[38]  
Khan J A, 1989, Ophthalmic Plast Reconstr Surg, V5, P227, DOI 10.1097/00002341-198912000-00001
[39]   SEBACEOUS CARCINOMA OF THE SKIN WITH VISCERAL METASTASES [J].
KING, DT ;
HIROSE, FM ;
GUREVITCH, AW .
ARCHIVES OF DERMATOLOGY, 1979, 115 (07) :862-863
[40]   Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? [J].
Kruse, R ;
Lamberti, C ;
Wang, YP ;
Ruelfs, C ;
Bruns, A ;
Esche, C ;
Lehmann, P ;
Ruzicka, T ;
Rutten, A ;
Friedl, W ;
Propping, P .
HUMAN GENETICS, 1996, 98 (06) :747-750